Roche unit Genentech's obesity drug shows up to 10.7% weight loss in mid-stage trial

Genentech, part ​of ‌Roche , said ​on ​Thursday that its ⁠experimental ​obesity ​drug helped people ​lose ​up to 10.7% ‌of ...
The Caledonian-Record

Genentech Announces Positive Phase II Results for Petrelintide, an Amylin Analog Developed for People Living With Overweight and Obesity

Genentech, a member of the Roche Group (SIX: RO, ROG; OTCQX: RHHBY), announced today positive topline results from the Phase II ZUPREME-1 trial evaluating investigational petrelintide versus placebo ...

Novartis, Genentech file suit alleging illegal importation of prescription drug

Novartis and Genentech are suing a U.S. company and a Canadian pharmacy over the importation of a Canadian version of their allergy medicine.

Roche succeeds in mid-stage trial for obesity drug developed with Zealand

Roche (RHHBY) (RHHBF) stock is in focus as obesity therapy petrelintide succeeds in a mid-stage trial, causing up to 11% weight loss on average. Read more here.
Fierce Pharma

Sanofi, Genentech, Kedrion back star-studded bleeding disorder awareness campaign

A handful of pharmas and celebrities are joining forces with the National Bleeding Disorders Foundation (NBDF) for a ...

Genentech's Fenebrutinib Confirms Its Potential as First and Only BTK Inhibitor for Relapsing and Primary Progressive MS in Third Positive Phase III Study (FENhance 1)

Genentech, a member of the Roche Group (SIX: RO, ROG; OTCQX: RHHBY), announced today that the pivotal Phase III study (FENhance 1) of fenebrutinib in RMS met its primary endpoint, showing clinically ...
STAT

Genentech weighs slow-walking ovarian cancer therapy to make more money under drug pricing reform

WASHINGTON — Plenty of pharmaceutical executives have decried Democrats’ new drug pricing law as detrimental to the industry. But few are willing to say they may be willing to delay treatments for ...
MM&M

Genentech taps Lorde’s ‘Royals’ director for film on rare disease caregivers

Genentech is honing in on an aspect of the patient community that is too often overlooked — the role of caregivers in managing rare diseases. In a recently-released short film, Genentech tells the ...
Yahoo Finance

Genentech’s Fenebrutinib Is the First Investigational Medicine in Over a Decade That Reduces Disability Progression in Primary Progressive Multiple Sclerosis (PPMS)

– Late-breaking Phase III FENtrepid results presented at ACTRIMS show investigational fenebrutinib met its primary endpoint of non-inferiority compared to the current standard of care, Ocrevus, in ...
San Diego Union-Tribune

Genentech expands in Oceanside with $450M biotech manufacturing facility and 150 jobs

Biotechnology company Genentech is expanding its local manufacturing capabilities with a $450 million investment in its Oceanside campus. Genentech was founded in 1976 and has been considered a ...
STAT

EPA fines Roche’s Genentech unit for hazardous waste violations

Following an extensive inspection, the Environmental Protection Agency fined Genentech more than $158,000 for hazardous waste violations at a facility in California, the latest instance in which a ...